Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay. [PDF]
Sci RepPriyadharshini A +4 more
europepmc +1 more source
Improving CYP2C19 phenotyping using stereoselective omeprazole and 5-hydroxy-omeprazole metabolic ratios. [PDF]
Basic Clin Pharmacol ToxicolAbouir K +4 more
europepmc +1 more source
Use of Proton Pump Inhibitors and risk of gastric cancer. [PDF]
Turk J Gastroenterol, 2018 Karakan T.
europepmc +1 more source
Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients. [PDF]
Indian Heart JChoudhary R +6 more
europepmc +1 more source
An Unusual Presentation of QT Prolongation. [PDF]
Tex Heart Inst J, 2016 Mojadidi MK +3 more
europepmc +1 more source
Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux. [PDF]
Braz J Med Biol Res, 2016 Liu C, Wang H, Liu K.
europepmc +1 more source
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease. [PDF]
Gut Liver, 2018 Gweon TG +9 more
europepmc +1 more source
Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis. [PDF]
Yonsei Med J, 2018 Song IJ, Kim HK, Lee NK, Lee SK.
europepmc +1 more source
Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series. [PDF]
Medicine (Baltimore), 2016 Dore MP +5 more
europepmc +1 more source